West Columbia, SC — West Columbia, South Carolina

West Columbia, SC is a clinical research site located in West Columbia, South Carolina, United States 29169.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

West Columbia, SC has participated in 4 clinical trials with 3 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO), Diabetic Macular Edema (DME).

Sponsors: EyeBiotech Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in West Columbia

Browse all research sites in South Carolina · View every site in West Columbia

• University of South Carolina
• Lexington Medical Center
• Julio Arroyo
• Palmetto Retina Center
• Southern Urogynecology
• Research Site
• Invocare Clinical Research Center
• Regeneron Study Site
• Novartis Investigative Site
• West Columbia
• Lexington Health

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for West Columbia, SC?

West Columbia, SC has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has West Columbia, SC conducted?

West Columbia, SC has 4 clinical trials on record, with 3 currently active. Their work covers Neovascular Age-Related Macular Degeneration (NVAMD), Branch Retinal Vein Occlusion (BRVO), Diabetic Macular Edema (DME).

Is West Columbia, SC accredited by Crixeo Clinical Trials?

West Columbia, SC has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about West Columbia, SC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.